The E2F family of transcription factors are critical regulators of the cell cycle and have also been implicated in apoptosis, development, DNA damage checkpoints, and differentiation. Retinoblastoma (Rb) proteins interact with E2F to regulate transcription, and several mechanisms have been proposed for Rb-E2F transcriptional regulation. We designed microarray-based experiments to characterize the relative contributions of each mechanism, and unexpectedly, we found that distinct functional gene groups show preference for one mechanism over the others. We propose that such a distribution may provide signaling specificity to enable regulatory proteins to turn on or off entire pathways that determine cell fate.
The E2F family of transcription factors control cell proliferation by regulating entry into the cell cycle as well as the G 1 -S phase transition. E2Fs bind to pocket proteins collectively known as the Rb family, consisting of Rb, p107, and p130. The pocket proteins inhibit E2F transcriptional activity and also repress transcription when recruited to E2F-responsive promoter elements (Dyson, 1998) . E2Fs1, 2, and 3 are thought to be primarily involved in transcriptional activation, while E2Fs4 and 5 are thought to be important for transcriptional repression (Trimarchi and Lees, 2002) . E2Fs1-3 transactivate key cell cycle genes such as a number of cyclins, replication factors, and enzymes involved in nucleic acid synthesis. Overexpression of E2F1 in serumstarved, G 0 -arrested cells is sufficient to drive them into S phase (Johnson et al., 1993) . However, in G 0 -arrested cells that are induced to proliferate by mitogens (i.e., readdition of serum or growth factors), physiological E2F1-3 levels do not rise until late G 1 phase, activating their target genes in late G 1 -S phase (Dyson, 1998) , and thus are thought to primarily mediate transition from G 1 to S phase.
Beyond the cell cycle, E2Fs have been implicated in the regulation of apoptosis, development, and differentiation . Despite the recent broadening of the appreciated roles for E2Fs, the mechanism(s) by which Rb/E2F regulate these gene groups have not been well characterized. Two prevailing and opposite models exist for transcriptional regulation by E2Fs. In the first model, E2Fs activate transcription of target genes and Rb family members inhibit or 'neutralize' E2F transactivation (Hiebert et al., 1992; Flemington et al., 1993; Helin et al., 1993) . A supporting example of this is during S phase induction from G 0 arrest, where transactivation by E2F is essential, as a truncated mutant of E2F containing the DNA-binding domain but lacking the transactivation domain (E2Fdb) is unable to drive serum-starved cells into S phase (Johnson et al., 1993) , although it is able to derepress genes which are bound by Rb-E2F. In the second model, E2Fs serve as a tether to recruit Rb family members to target genes where they actively repress transcription, usually in association with chromatin-remodeling enzymes, such as HDACs, BRM/BRG1, Suv39H1 and 2, and HP1 (Dunaief et al., 1994; Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998; Nielsen et al., 2001; Vandel et al., 2001) . A supporting example of this is during p16-, TGF-b-, and contact inhibition-induced cell cycle arrest, where active repression by Rb-E2F is operative, as overexpression of E2Fdb is able to overcome these arrests (Zhang et al., 1999) . It is conceivable that some genes are regulated predominantly by transactivation, while others predominantly by repression, and/or that both mechanisms could contribute to transcriptional regulation by Rb and E2F at the same target gene. This latter possibility is supported by the finding that E2F4 (the major repressor E2F) binds to cell cycle gene promoters in G 0 and early G 1 , and is replaced by E2Fs1-3 (the activator E2Fs) in late G 1 and S phases (Takahashi et al., 2000) .
One approach to test which mechanism predominates at a given gene is to mutate the E2F-binding sites in the target gene promoter and observe the result on gene expression. This would have to be done via artificial promoter-reporter constructs. For most genes studied in this fashion, mutation of E2F sites increases expression (Dalton, 1992; Lam and Watson, 1993; Hsiao et al., 1994; Johnson et al., 1994; Neuman et al., 1994; Ohtani et al., 1995; Geng et al., 1996; Sears et al., 1997) , suggesting that E2F is responsible for repression at these genes. A minority of genes show decreased expression (Means et al., 1992; Wade et al., 1992) , suggesting that E2F is responsible for transactivation at these genes. The disadvantage of this approach is that reporter constructs are not subject to the same chromatin structure and remodeling that the endogenous gene promoters are, and pocket proteins have become increasingly recognized to rely upon chromatin remodeling for their transcriptional regulation (Harbour and Dean, 2000) . A second approach is to overexpress E2F1 and E2Fdb and study their effects on E2F target gene expression. When a gene's expression is induced by E2Fdb, this suggests repression by Rb-E2F, and when a gene's expression is either reduced or remains the same with E2Fdb while full-length E2F1 induces the gene, this suggests transactivation by E2F. Currently, since only a few selected genes have been studied with these approaches, the relative contributions of each mechanism to E2F target genes on a genomic scale are not known. In addition, the relative roles of transactivation vs repression in E2F-regulated biological pathways other than the cell cycle have not been characterized.
To address these questions, we designed a microarraybased approach to determine the contributions of each mechanism to transcriptional regulation by Rb/E2F during the G 1 to S phase transition. We generated stable cell lines expressing either E2F1 (EEE) or E2Fdb (EdbE) fused to the modified estrogen receptor (ER) to allow for conditional, post-translational activation of E2F1 or E2Fdb following addition of 4-hydroxytamoxifen (4OHT). In these cells, E2F1-ER or E2Fdb-ER is constitutively expressed, but inactive until addition of 4OHT, thereby allowing for the use of the protein synthesis inhibitor cycloheximide (CHX) to restrict the readout to only primary targets of E2F1 or E2Fdb. The parental cell line was EH1, a U2OS-based line that contains a stably integrated, IPTG-inducible p16 cassette. p16 is a cyclin-dependent kinase inhibitor (cdki) that induces accumulation of hypophosphorylated (active) Rb. U2OS is an osteosarcoma line that is Rb( þ ), p16(À), and p53( þ ). Induction of p16 in EH1 cells results in a G 1 cell cycle arrest that is dependent on endogenous Rb (McConnell et al., 1999) . Our cells were thus independently inducible for p16 and for E2F1 or E2Fdb. p16 in our system served three purposes: (1) to set up a G 1 phase cell cycle arrest dependent on endogenous Rb; (2) to drive expression of E2F-responsive genes to basal levels, thereby making our readout more sensitive for E2F target genes; and (3) to set up active repressor complexes at promoters that could be displaced by either E2Fdb-ER or E2F1-ER. The characterization of these cell lines is described in a separate report.
p16 expression was first induced to establish a G 1 arrest, and then 4OHT was added to activate E2F1-ER or E2Fdb-ER. CHX was added along with 4OHT. This concentration of CHX inhibited overall protein synthesis by 98% in these cells, completely blocked induction of cyclin A (an E2F1 induced gene) protein without affecting cyclin A mRNA, and caused growth arrest for 2 days without apparent toxicity (data not shown). For microarray analysis,
Analyses were carried out with a total of four repetitions for three clones of EEE and three repetitions of two clones for EdbE. Reproducibility between clones was found to be high.
To determine which genes changed significantly, we used the significance analysis of microarrays method (SAM) (see Materials and methods). A large number of genes showed significant change in EEE or EdbE cells. Instead of the anticipated two major categories of affected genes -those induced by E2F1 but not E2Fdb (i.e. 'transactivated'), and those induced by both (i.e. 'derepressed'), we found four major categories of genes: those induced by E2F1 and not E2Fdb (A), those induced by both (B), those repressed by E2F1 but not E2Fdb (C), and those repressed by both (D). There were a smaller number of genes induced by E2Fdb but not by E2F1, or repressed by E2Fdb but not E2F1. Of the 12 533 genes on the Affymetrix Hu95A array, 803 were in category (A), 225 in category (B), 1108 in (C), and 107 in (D). Of 64 genes in all the four categories tested thus far by Northern blot, 63 were confirmed, with one false positive ( Figure 1 and data not shown). Quantitative real-time PCR confirmed 12 of 13 genes tested (data not shown). Thus, we observed an overall false-positive rate of B3% by independent testing. The results for all genes that changed can be found in Supplemental Data, and the full microarray results can be found on the website http://bioinformatics.wustl.edu.
Percentages for the major categories (A-D) are shown in Table 1 . Of all genes in the major categories, 35.8% were in category (A) and 10.0% in (B). Thus, of genes that were upregulated, 78.2% appeared to require transactivation (A/A þ B) and 21.8% required only derepression (B/A þ B). Of genes that were derepressed (B), many were upregulated to a greater extent by E2F1 than by E2Fdb, suggesting that both derepression and transactivation could potentially contribute to regulation of these genes.
We were surprised to find a large number of genes that were downregulated by E2F1. This accounted for over 54% (C þ D) of all genes in the major categories. Given that CHX was used to inhibit protein synthesis, downregulation on such a large scale was not expected, since there has been limited evidence of direct repression by E2F1 in the literature (Koziczak et al., 2001; Croxton et al., 2002) . In a parallel report (Young and Longmore, submitted), we describe evidence for a mechanism for transcriptional repression by E2F1 to explain the genes in category (C). We found that Rb repressor complexes that accumulate at target gene promoters in the presence of p16 were not diminished even by overexpression of E2F1. Overexpression of E2F1 actually recruited more Rb to promoters, resulting in gene repression. Based on this mechanism, we propose that this category (C) of genes also represents genes where E2F and Rb act together to repress transcription. Some of these genes in category (C) were repressed by activated Rb, induced in RbÀ/À MEFs, and induced by E1A overexpression, which inhibits Rb (Young and Longmore, submitted and data not shown), just as genes in categories (A) and (B) (Young and Longmore, submitted and data not shown). However, almost none of the genes repressed by E2F1 (C) were induced by E2Fdb (as with category (B); supplemental data), highlighting a clear mechanistic distinction between genes that can be derepressed (B) and genes where E2F1 recruits additional Rb to further repress gene expression (C). Therefore, while Rb clearly represses transcription for genes in categories (A)-(C), these three categories appear to represent distinct mechanisms of Rb-E2F action.
Many of the genes clustered into easily recognizable functional groups (selected examples are shown in Table 2 ). Included among these groups were processes that have classically been known to be regulated by E2Fs, such as cell cycle control genes, replication factors, and proapoptotic genes. A number of new genes in these groups were identified by the assays, for example cell cycle control genes such as p57Kip2 and cyclin E2 and replication factors such as Cdc45L and DNA polymerase epsilon (Table 2 ). Additionally, we found a number of developmental genes and DNA repair genes, areas that have recently been linked to E2F control (Suzuki and Hemmati-Brivanlou, 2000; Polager et al., 2002; Ren et al., 2002) . Notably, we discovered several novel gene groups with significant numbers of representative genes. Among the novel groups were growth factors, histones, death receptor signaling genes, TGF-b/BMP genes, basal transcription machinery, peroxisomal genes, and melanoma-associated genes (Table 2 and data not shown).
The most interesting and unexpected finding of these analyses was that certain functional gene groups seemed to be strongly prejudiced toward one particular mechanism (Tables 2 and 3 ). The majority (67%) of replication factors fell into category (A) (10/15, compared to 35.8% of all genes in category (A); P ¼ 1.5 Â 10 À2 ). Of all homeobox genes identified, 59% (13/22) were induced by both E2F1 and E2Fdb (category (B), which was 10.0% overall; P ¼ 2.2 Â 10 À8 ). Of the remaining nine not induced by E2Fdb, four were borderline to 'no change' for E2F1 (PROX1, PHOX1, HoxA7, HB9), and one was borderline to 'increased' for E2Fdb (Pbx3). Growth factors also showed bias toward (B), with 60% (9/15) induced by both E2F1 and E2Fdb (P ¼ 2.9 Â 10 À6 ). Category (C) (downregulated by E2F1 but not by E2Fdb; 45.0% overall) had the largest number of biological pathways that segregated into it, and the highest percentage of genes within the groups consistently falling into (C). 84% (16/19) of histones fell into category (C) (compared to 49.4% overall; P ¼ 1.9 Â 10 À3 ). Also in (C) were 86% (18/21) of DNA repair genes (P ¼ 6.2 Â 10 À4 ), 90% (9/10) of peroxisomal genes (P ¼ 9.7 Â 10 À3 ), and 100% (12/12) of melanomaassociated genes (P ¼ 2.1 Â 10 À4 ). Genes in category (D) (downregulated by both E2F1 and E2Fdb) were the most infrequent, accounting for only 4.8% of the total; nonetheless, antiapoptotic genes were biased toward this mechanism (60%, 6/10; P ¼ 2.1 Â 10 À6 ). Interestingly, of these six, three were subunits of the dimeric NFkB transcription factor (NFkB1, NFkB2, and RelB), and two were TNFR-associated factors that activate NFkB (Traf2, Traf6). Another NFkB subunit, Rel, fell into category (C). Although segregation of death-receptorrelated genes into category (C) was not statistically Figure 1 Northern blots of EEE25 (E2F1-ER), EdbE14 (E2Fdb-ER), and EH1 (parental) cells for selected gene groups that show bias toward one mechanism: replication factors (a), homeobox genes (b), histones (c), and antiapoptotic genes (d). Experiments were the same as those described in Table 1 . Supplemental data: The four separate tables show the full set of genes in categories (A)-(D) (described in text). The Affymetrix probeset, the accession number, the fold changes for each of the seven independent microarray experiments (EEE are E2F1 experiments and EdbE are E2Fdb experiments), the gene abbreviation, and the gene name, where available, are shown. Fold changes were computed by the Affymetrix MAS 5.0 comparison analysis. EEE or EdbE cells were induced for p16 with 1 mm IPTG (Fisher) for 44 h, and then treated with 200 mg/ml CHX (Sigma) and 100 nm 4OHT (Sigma) or EtOH for 20 h. Three independent clones for E2F1-ER (EEE3, EEE4, and EEE25) and two clones for E2Fdb-ER (EdnE7 and EdnE14) were used for four and three independent microarray experiments, respectively. SAM was used to identify genes that significantly changed when induced samples were compared with control samples significant, seven genes in this group fell into category (C): Fas, TNFa, TNFR, TRAIL receptor 2, caspase 8, I-Traf, and CFLAR (Table 2) . Some of these patterns were confirmed by Northern blotting (Figure 1 ). Previous studies to identify new E2F target genes have been performed on p16(À) cells, where most of the endogenous Rb is inactive and E2F basal activity is therefore high , or using serumstarved, G 0 -arrested rodent cells (Ishida et al., 2001; Kalma et al., 2001) . Cells arrested in G 0 can be induced to enter the cell cycle and S phase by overexpression of E2F1 (Johnson et al., 1993) , but normally E2F1 levels in G 0 are very low, rising sharply at the G 1 -S phase transition in response to mitogenic induction (Hsiao et al., 1994; Johnson et al., 1994; Neuman et al., 1994) .
Thus, when E2F1 is ectopically expressed in serumdeprived cells, the mitogenic signaling pathways that are normally activated along with E2F1-3 in response to growth factor stimulation (i.e. readdition of serum) are not active. Furthermore, in these studies, no distinction was made between direct and indirect targets on a whole genome level. A novel approach has been used to identify promoters bound by physiological E2F by combining chromatin immunoprecipitations with microarray analyses (Ren et al., 2002; Weinmann et al., 2002) . In our studies, we established G 1 arrest via endogenous Rb, allowing for analysis of the G 1 -S phase transition; and we used a post-translationally regulatable E2F1 or E2Fdb in the presence of CHX to restrict our readout to primary targets of E2F. The comparison of gene profiles for E2F1 and E2Fdb allowed for mechanistic insight into the actions of E2F on a genomic scale.
Our observation of such widescale repression by E2F1 was consistent with other studies that have made similar observations (Koziczak et al., 2001; Croxton et al., 2002; Ma et al., 2002) , although here we showed that most of the repression by E2F1 was direct. However, it is notable that a number of studies have found gene induction by E2F1 overexpression to be more predominant than gene repression. Some genes that we found to be repressed by E2F1 were found by other groups to be induced (e.g., cyclin B, Ishida et al., 2001) . Also, Muller et al. (2001) reported that most of the genes they found to be repressed by E2F1 were indirect targets, as repression was abrogated with addition of CHX Gene groups are shown in their entirety except for those marked by (*). Fold induction is the average of four total independent experiments for three clones for E2F1-ER and three total experiments for two clones for E2Fdb-ER using the Affymetrix MAS 5.0 comparison analysis.
Regular text denotes genes in category (A) (see text); bold text category (B), italics (C), and bold italics (D)
. All experiments were done as described in Table 1 
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Peroxisomal genes (C) 9/10 (90) 9.7 Â 10 Category: mechanistic category (see text). x/y ¼ fraction of genes in the biological pathway that fall into the specified category; in parentheses is the percentage value. For P-value calculation, see Materials and methods.
Mechanisms of Rb-E2F transcriptional regulation AP Young et al (Muller et al., 2000;  although several examples of direct repression were shown by Northern blot). Our finding of widescale repression may in part be due to our activation of E2F1-ER in the presence of p16 expression, where endogenous active Rb accumulates. Additionally, it is possible that repression by E2F1 is less likely to be seen in Rb-positive cells in the absence of CHX. cdk2, cdk4, cyclin D3, cyclin E, and cyclin E2, all of which cooperate to phosphorylate and inactivate Rb, are targets of E2F; so induction of these genes may make it impossible for E2F1 overexpression to recruit additional Rb to target promoters, which is the basis for direct E2F1 transcriptional repression (Young and Longmore, submitted). It is also interesting that all of the classic cell cycle targets of E2F (e.g., cyclin A, cyclin E, Cdc25a, PCNA) were induced in our experiments rather than repressed. Although the segregation of mechanisms by biological pathway was unexpected, it could potentially address two pressing questions that emerge every time a new biological pathway is found to be regulated by E2F. (1) Is E2F really important physiologically for all these processes? and (2) Are all these pathways induced every time E2F activity is increased, for example, in late G 1 of every cell cycle? Our results suggest the possibility that a cell might be able to activate one or a few specific pathways to the exclusion of others by regulating one specific mechanism of transcriptional regulation by Rb-E2F. If so, then how could a cell trigger the activity of one mechanism of Rb-E2F transcriptional regulation while leaving the others unaffected?
Rb is inactivated at the G 1 -S phase transition via a two-step process: first, cyclin D/cdk4/6 partially phosphorylates Rb, disassociating HDAC from Rb, resulting in derepression; then, cyclin E/cdk2 further phosphorylates Rb, releasing E2F from Rb, resulting in transactivation (Harbour et al., 1999) . Cyclin D amplification, cdk4 amplification or activating mutations, p16INK4a (which specifically inhibits cdk4) deletion or methylation of its promoter, cyclin E amplification, and cdk2 amplification have all been found in human cancers (Sherr, 1996; Reed, 1997) ; thus, there may be situations where derepression but not transactivation occurs, or vice versa. Additionally, a number of corepressors or cofactors for Rb function have been characterized, such as HDAC (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) , BRG1/BRM (part of the SWI/SNF complex) (Dunaief et al., 1994) , SUV39H1/2, and HP1 (Nielsen et al., 2001; Vandel et al., 2001) . It is conceivable that any of these cofactors could be regulated specifically, thus 'fine-tuning' the degree of Rb-mediated repression without affecting the activity of other cofactors or the binding of E2F. For example, mutation of hSNF5, a subunit of SWI/SNF, has been observed in human cancer (Muchardt and Yaniv, 1999) .
A number of scenarios exist where this segregation of mechanisms could potentially be important. Early studies of E2F recognized that expression of E2F1 in quiescent (G 0 -arrested) cells could induce DNA replication and drive cells into S phase, while E2Fdb was unable to drive cells into S phase (Johnson et al., 1993) . Our finding that induction of many replication factors (category A) depends on E2F1 transactivation provides a possible mechanistic explanation for this observation. Although this was borderline significant statistically, it is perhaps biologically significant that at least ten replication factors depend on transactivation by E2F.
Genes downregulated by E2F1 (category C) in the presence of active Rb are similar to genes upregulated by both E2F1 and E2Fdb (category B) in that Rb-E2F actively represses transcription for both sets of genes. However, the clear distribution of these genes into one category to the complete exclusion of the other by functional group suggests that they are regulated in distinct ways. Based on the mechanism we have elucidated for (C), it would seem that these genes have the capability of being repressed by Rb-E2F but are less sensitive to this repressive effect than genes in (B). In other words, these genes require a higher threshold of Rb-E2F levels in order to respond, which is provided by recruitment of Rb to these promoters when E2F1-ER is activated. One would then expect that these genes, which include histones and DNA repair genes, would be especially repressed in environments with particularly high Rb activity, such as during differentiation (Wang and Walsh, 1996) . While it is unlikely that the cells used in these assays are representative of diverse differentiated tissues, several of the genes in (C) were repressed following differentiation of myoblasts into myotubes, induction of p16, or treatment of keratinocytes with TGF-b (Young and Longmore, submitted).
While our analyses were restricted to only one cell line, the observed segregation of mechanisms into biological pathways is unlikely to be coincidental. Our results suggest that general processes such as DNA repair, development, histone expression, and DNA replication can be controlled by altering the relative activities of E2F and Rb-E2F. This would allow the shutting on or off of whole functional gene groups by one regulatory factor -a 'master switch' -that signals to E2F or to Rb. The relative activities of E2F and Rb-E2F, and thus the predominant mechanism, could be determined by regulating the activity of corepressors or coactivators, the activity of the cyclin/cdks/cdkis, the level of Rb, or the level of active E2F. E2F has been connected to many diverse biological pathways, and it is possible that E2F is a crucial switch for many of these pathways. The possibility of being able to activate or repress one or a few of these pathways to the exclusion of others may provide the signaling specificity required to direct cell fate along an appropriate path.
Materials and methods
RNA preparation, high-density oligonucleotide arrays, and Northern analysis RNA was isolated with the RNeasy kit (Qiagen) and used for hybridization to microarrays or Northern blot. PolyA RNA was isolated from total RNA using the Oligotex mRNA kit (Qiagen) and was used for Northern blot.
Three independent clones for E2F1-ER (EEE3, EEE4, and EEE25) and two clones for E2Fdb-ER (EdnE7 and EdnE14) were used for four and three independent microarray experiments, respectively. Labeled cRNA was prepared from total RNA according to the manufacturer's instructions (Enzo BioArray). cRNA was hybridized to Affymetrix Hu95A microarrays according to the Affymetrix protocol. Images were scanned at 3-mm resolution using a Hewlett-Packard GeneArray Scanner. The images were analysed using Affymetrix's GeneChip s software. Northern blots were hybridized with 
Statistical analysis of the microarray data
Four independent microarray experiments were performed for E2F1 using three different clones, and three independent experiments were performed for E2Fdb using two different clones. To identify those probesets that were either induced or repressed significantly, data from the eight microarrays for E2F1 and six microarrays for E2Fdb were analysed by the SAM method (Tusher et al., 2001) . Prior to conducting SAM analysis, the raw data were subject to an initial filtering step and normalization as follows. Briefly, those probesets, which were called 'Present' by the Affymetrix Microarray Application Suite (MAS) 5.0 Software on at least one microarray and whose expression was either induced or repressed by twofold or greater (the fold change of each probeset was calculated by dividing the absolute signal intensity from the induced sample by that of the control sample) in at least one experiment, were subject to normalization and SAM analysis. The raw data for each control or induced sample were normalized by subtracting the mean and dividing the result by the standard deviation of expression across all samples. The delta value, a measure related to the standard deviation of expression levels in the full data set and thus a measure of stringency for the analysis, was set identically for E2F1 and E2Fdb at d ¼ 1.8525. The calculated median false significant rates were 0.17% for E2F1 and 1.69% for E2Fdb.
To calculate P-values for each of the biological groups (the probability that probesets within each group segregated into the mechanistic categories at random), we used the following formula:
X r n ½ðxÞ n þ ð1 À xÞ rÀn ½r!=ðn!ðn À rÞ!Þ where r ¼ the number of probesets in a given biological group that fall into a particular category, n ¼ the number of genes in that biological group that were found to change significantly, and x ¼ the fraction of all the probesets that were found to change on the microarray that fall into that particular category. For example, for 10 out of 15 replication factors falling into category A, r ¼ 15, n ¼ 10, and x ¼ 0.358.
